NOESIS

Medical knowledge is inherently complex and uncertain. Medical experts may provide different interpretations for symptoms since all of them also depend on a given context and most of them are established by statistical utilisation. In the United Kingdom a pilot study found a 10% adverse event rate, of which half were preventable.

NOESIS will develop an intelligent environment that enables ubiquitous management of citizens' health status and to assist health professionals in coping with some major challenges, risk management and the integration into clinical practice of advances in health knowledge. The selected clinical domain addressed by the project will be Cardiology.

In particular NOESIS will contribute to:

• Reduce the uncertainty in diagnosis of diseases, focusing on cardiovascular diseases.
• Support the process of diagnosis and treatment by reducing errors and minimising risks.
• Enhance the quality of medical care provided through the use of decision support mechanisms.
• Provide methods for establishing trust and confidence of users towards information sources.

For further information, please visit:
http://www.noesis-eu.org

Project co-ordinator:
Boehringer Ingelheim Italia S.p.A.

Partners:

• Boehringer Ingelheim Italia S.P.A. (IT)
• Siemens S.A. (ES)
• Airial Conseil (FR)
• Universite Joseph Fourier Grenoble (Timc Laboratory) (FR)
• Centre Hospitalier Regional Universitaire de Grenoble (FR)
• Sesa Ltd. (AT)
• University of Ioannina (GR)
• Hellenic Cardiological Society (GR)
• Medisell Co. Ltd. (CY)
• M.R.I. Lefkothea Medical Services (CY)
• Business Flow Consulting (FR)

Timetable: from 01/04 – to 12/06

Total cost: € 7.715.793

EC funding: € 4.400.000

Instrument: IP

Project Identifier: IST-2002-507960

Source: FP6 eHealth Portfolio of Projects